In this interview, Brian M. Slomovitz, MD, MS, discusses the impact of molecular classification on endometrial cancer treatment, the role of biomarkers in guiding therapy, and the promise of emerging strategies to address challenges in...
In this interview, Brian M. Slomovitz, MD, MS, discusses the impact of molecular classification on endometrial cancer treatment, the role of biomarkers in guiding therapy, and the promise of emerging strategies to address challenges in...
In this interview, Brian M....